Metabolomics-guided network pharmacology and molecular modeling suggest bioactive components of Chiliadenus montanus associated with multi-target anticancer and anti-inflammatory activities
Medical Oncology · 2026
DOI: 10.1007/s12032-026-03340-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Oncology, 2026. Verfasst von Ghazi A Bamagous und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Network Pharmacology, Metabolomics, Plant Extracts. Die Arbeit nennt 57 Literaturangaben.
Abstract (Originalsprache)
Chiliadenus montanus (Vahl.) Brullo (Asteraceae) is a traditional medicinal plant with reported anti-inflammatory properties; however, its potential anticancer activity and underlying molecular basis remain insufficiently characterized. In this study, a bioactivity-guided integrative approach combining metabolomics, biological evaluation, network pharmacology, and computational modeling was applied to explore the antiproliferative potential of the acetone extract of C. montanus (CME). CME exhibited cytotoxic activity against a panel of 14 human cancer cell lines (IC₅₀ = 1.41-24.78 µg/mL), with HepG2, Panc-1, and HCT-116 cells showing the highest sensitivity relative to a normal fibroblast control (selectivity index > 13). Flow cytometry analysis revealed substantial apoptosis induction and cell-cycle perturbation at the G₀/G₁ and S phases. Consistently, protein expression analysis showed upregulation of p53, Casp7, and BAX together with downregulation of BCL-2, resulting in an increased BAX/BCL-2 ratio across the responsive cell lines, supporting activation of mitochondrial apoptotic signaling. UPLC-TOF-MS/MS profiling tentatively identified 162 metabolites, predominantly flavonoids and organic acids, including luteolin, naringenin, kaempferol derivatives, and γ-linolenic acid. Network pharmacology identified 87 overlapping targets associated with liver cancer-related pathways, highlighting COX-1 (PTGS1), 5-LOX (ALOX5), and oxidative-stress-related proteins as central nodes. Consistent with these predictions, CME inhibited COX-1 and 5-LOX activity (in vitro) with IC₅₀ values of 7.25 µg/mL and 3.21 µg/mL, respectively, and displayed antioxidant activity in DPPH, ABTS, and FRAP assays. Moreover, CME reduced cellular levels of PGE₂, IL-6, and TNF-α in HepG2 cells, indicating suppression of inflammatory signaling. Molecular docking further suggested favorable interactions between several identified metabolites and inflammation-related targets. Overall, CME activity is associated with modulation of apoptotic and inflammatory signaling pathways, supported by biochemical, cellular, metabolomic, and computational analyses. While these findings provide mechanistic insights into the biological activity of C. montanus, further studies, including compound isolation and in vivo validation, are required to confirm these effects and their therapeutic relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
- Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.
- Makkah Cluster, Laboratory Department, Al-Noor Specialist Hospital, Makkah, Saudi Arabia.
- Department of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Al Abdeyah, Makkah, 24381, Saudi Arabia.
- College of Science, Chemistry Department, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11623, Saudi Arabia.
- Biology Department, College of Science and Humanities, Prince Sattam bin Abdulaziz University, P.O. Box: 83, Al-Kharj, 11940, Saudi Arabia.
ORCID-Profile: Essa M Saied
Zitieren
APA
Bamagous, G. A., Almasmoum, H. A., Ghaith, M. M., Alhakami, R. F., Mukhtar, M. H., Eissa, M. E., Al-Hazani, T. M. I., Alshawwa, S. Z., Alrashidi, A. A., Nahas, H. H. A., & Saied, E. M. (2026). Metabolomics-guided network pharmacology and molecular modeling suggest bioactive components of Chiliadenus montanus associated with multi-target anticancer and anti-inflammatory activities. Medical Oncology. https://doi.org/10.1007/s12032-026-03340-4
Vancouver
Bamagous GA, Almasmoum HA, Ghaith MM, Alhakami RF, Mukhtar MH, Eissa ME, et al. Metabolomics-guided network pharmacology and molecular modeling suggest bioactive components of Chiliadenus montanus associated with multi-target anticancer and anti-inflammatory activities. Medical Oncology. 2026. doi:10.1007/s12032-026-03340-4
BibTeX
@article{Bamagous2026,
author = {Bamagous, Ghazi A and Almasmoum, Hussain Ali and Ghaith, Mazen M and Alhakami, Rayan Fawaz and Mukhtar, Mohammed Hasan and Eissa, Mohamed E and Al-Hazani, Tahani M I and Alshawwa, Samar Zuhair and Alrashidi, Amal Abdullah and Nahas, Hebatallah H Abo and Saied, Essa M},
title = {Metabolomics-guided network pharmacology and molecular modeling suggest bioactive components of Chiliadenus montanus associated with multi-target anticancer and anti-inflammatory activities},
journal = {Medical Oncology},
year = {2026},
doi = {10.1007/s12032-026-03340-4}
}
EUVIMED